These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6168929)

  • 1. Successful immunization against experimental allergic encephalomyelitis with myelin basic protein-sensitized allogeneic lymphocytes.
    Hashim GA
    Neurochem Res; 1981 Jun; 6(6):699-718. PubMed ID: 6168929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of myelin lipids in experimental allergic encephalomyelitis. III. Transfer of suppression from guinea pigs recovering from EAE, induced by myelin basic protein--galactocerebroside complexes.
    Hosein ZZ; Gilbert JJ; Strejan GH
    Cell Immunol; 1986 Apr; 99(1):265-78. PubMed ID: 2428529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species.
    Miller A; Lider O; al-Sabbagh A; Weiner HL
    J Neuroimmunol; 1992 Aug; 39(3):243-50. PubMed ID: 1379607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal immunoglobulin G protects against experimental allergic encephalomyelitis by inducing transferable T cell unresponsiveness to myelin basic protein.
    Pashov A; Dubey C; Kaveri SV; Lectard B; Huang YM; Kazatchkine MD; Bellon B
    Eur J Immunol; 1998 Jun; 28(6):1823-31. PubMed ID: 9645363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the antigen specificity and TCR repertoire, and TCR-based DNA vaccine therapy in myelin basic protein-induced autoimmune encephalomyelitis in DA rats.
    Miyakoshi A; Yoon WK; Jee Y; Matsumoto Y
    J Immunol; 2003 Jun; 170(12):6371-8. PubMed ID: 12794171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of experimental allergic encephalomyelitis by MBP-coupled lymphoid cells and by MBP-liposomes: a comparison.
    Strejan GH; St Louis J
    Cell Immunol; 1990 May; 127(2):284-98. PubMed ID: 1691689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming unresponsiveness in experimental autoimmune encephalomyelitis (EAE) resistant mouse strains by adoptive transfer and antigenic challenge.
    Shaw MK; Zhao XQ; Tse HY
    J Vis Exp; 2012 Apr; (62):e3778. PubMed ID: 22507967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of treatment with glutaraldehyde-fixed myelin basic protein-liposomes on active induction and passive transfer of experimental allergic encephalomyelitis in Lewis rats.
    Strejan GH; Gilbert JJ; St Louis J
    Cell Immunol; 1988 Oct; 116(1):250-6. PubMed ID: 2458844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of experimental allergic encephalomyelitis in the Lewis rat, by administration of an acylated synthetic peptide of myelin basic protein.
    St Louis J; Chan EL; Singh B; Strejan GH
    J Neuroimmunol; 1997 Mar; 73(1-2):90-100. PubMed ID: 9058764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of experimental allergic encephalomyelitis in Lewis rats treated with myelin basic protein-liposome complexes: clinical, histopathological, and cell-mediated immunity correlates.
    Strejan GH; Percy DH; St Louis J
    Cell Immunol; 1984 Mar; 84(1):171-84. PubMed ID: 6199120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell vaccination prevents EAE effector cell development but does not inhibit priming of MBP responsive cells.
    Bouwer HG; Hinrichs DJ
    J Neurosci Res; 1996 Aug; 45(4):455-62. PubMed ID: 8872906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Lewis rats to experimental autoimmune encephalomyelitis after recovery from passively induced disease.
    Holda JH; Swanborg RH
    Immunol Commun; 1980; 9(4):333-40. PubMed ID: 6157638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-driven bystander suppression after oral administration of antigens.
    Miller A; Lider O; Weiner HL
    J Exp Med; 1991 Oct; 174(4):791-8. PubMed ID: 1717632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of experimental allergic encephalomyelitis with thoracic duct lymphocytes.
    Frost H; Swanborg RH
    Int Arch Allergy Appl Immunol; 1980; 63(2):153-8. PubMed ID: 6158482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acquisition of encephalitogenicity after sensitized cells are conditioned with myelin basic protein or concanavalin A.
    Levine S; Abreu SL; Sowinski R
    Cell Immunol; 1985 Feb; 90(2):599-604. PubMed ID: 2578332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of myelin lipids in experimental allergic encephalomyelitis. Part 2. Influence on disease production by encephalitogenic doses of myelin basic protein.
    Hosein ZZ; Gilbert JJ; Strejan GH
    J Neuroimmunol; 1986 Jan; 10(3):219-33. PubMed ID: 2416773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LF 15-0195 inhibits the development of rat central nervous system autoimmunity by inducing long-lasting tolerance in autoreactive CD4 T cells.
    Duplan V; Dutartre P; Mars LT; Liblau RS; Druet P; Saoudi A
    J Immunol; 2003 Feb; 170(4):2179-85. PubMed ID: 12574391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotropin inhibits experimental allergic encephalomyelitis (EAE) in Lewis rats.
    Naiki M; Takeoka Y; Kurimoto Y; Matsuoka T; Suehiro S; Imai Y; Osawa T; Gershwin ME
    Int J Immunopharmacol; 1991; 13(2-3):235-43. PubMed ID: 1712761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide.
    Khoury SJ; Sayegh MH; Hancock WW; Gallon L; Carpenter CB; Weiner HL
    J Exp Med; 1993 Aug; 178(2):559-66. PubMed ID: 7688026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive transfer of experimental allergic encephalomyelitis (EAE): prevention of successful transfer by treatment of donors with myelin basic protein.
    Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1975 Jan; 114(1 Pt 2):291-2. PubMed ID: 46879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.